BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

571 related articles for article (PubMed ID: 17350614)

  • 1. Comparison of the binding distribution of agonist and antagonist ligands for histamine H3 receptors in pig brain by quantitative autoradiography.
    Mezzomo K; Cumming P; Minuzzi L
    Eur J Pharmacol; 2007 Jun; 564(1-3):75-9. PubMed ID: 17350614
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological characterization of the novel histamine H3-receptor antagonist N-(3,5-dichlorophenyl)-N'-[[4-(1H-imidazol-4-ylmethyl)phenyl]-methyl]-urea (SCH 79687).
    McLeod RL; Rizzo CA; West RE; Aslanian R; McCormick K; Bryant M; Hsieh Y; Korfmacher W; Mingo GG; Varty L; Williams SM; Shih NY; Egan RW; Hey JA
    J Pharmacol Exp Ther; 2003 Jun; 305(3):1037-44. PubMed ID: 12649305
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of histamine H3 receptors in mouse brain using the H3 antagonist [125I]iodophenpropit.
    Jansen FP; Mochizuki T; Maeyama K; Leurs R; Timmerman H
    Naunyn Schmiedebergs Arch Pharmacol; 2000 Jul; 362(1):60-7. PubMed ID: 10935534
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies on the pharmacology of the novel histamine H3 receptor agonist Sch 50971.
    Hey JA; Aslanian R; Bolser DC; Chapman RW; Egan RW; Rizzo CA; Shih NY; Fernandez X; McLeod RL; West R; Kreutner W
    Arzneimittelforschung; 1998 Sep; 48(9):881-8. PubMed ID: 9793613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of the binding of the first selective radiolabelled histamine H3-receptor antagonist, [125I]-iodophenpropit, to rat brain.
    Jansen FP; Wu TS; Voss HP; Steinbusch HW; Vollinga RC; Rademaker B; Bast A; Timmerman H
    Br J Pharmacol; 1994 Oct; 113(2):355-62. PubMed ID: 7834183
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detailed pharmacological characterization of GT-2331 for the rat histamine H3 receptor.
    Ito S; Yoshimoto R; Miyamoto Y; Mitobe Y; Nakamura T; Ishihara A; MacNeil DJ; Kanatani A; Tokita S
    Eur J Pharmacol; 2006 Jan; 529(1-3):40-6. PubMed ID: 16316645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cloning and characterization of the monkey histamine H3 receptor isoforms.
    Strakhova MI; Fox GB; Carr TL; Witte DG; Vortherms TA; Manelli AM; Miller TR; Yao BB; Brioni JD; Esbenshade TA
    Eur J Pharmacol; 2008 Dec; 601(1-3):8-15. PubMed ID: 18977214
    [TBL] [Abstract][Full Text] [Related]  

  • 8. G protein-dependent pharmacology of histamine H3 receptor ligands: evidence for heterogeneous active state receptor conformations.
    Krueger KM; Witte DG; Ireland-Denny L; Miller TR; Baranowski JL; Buckner S; Milicic I; Esbenshade TA; Hancock AA
    J Pharmacol Exp Ther; 2005 Jul; 314(1):271-81. PubMed ID: 15821027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mapping of serotonin 5-HT(4) receptor mRNA and ligand binding sites in the post-mortem human brain.
    Bonaventure P; Hall H; Gommeren W; Cras P; Langlois X; Jurzak M; Leysen JE
    Synapse; 2000 Apr; 36(1):35-46. PubMed ID: 10700024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of multiple H3 receptor affinity states utilizing [3H]A-349821, a novel, selective, non-imidazole histamine H3 receptor inverse agonist radioligand.
    Witte DG; Yao BB; Miller TR; Carr TL; Cassar S; Sharma R; Faghih R; Surber BW; Esbenshade TA; Hancock AA; Krueger KM
    Br J Pharmacol; 2006 Jul; 148(5):657-70. PubMed ID: 16715122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and in vitro pharmacology of a series of new chiral histamine H3-receptor ligands: 2-(R and S)-Amino-3-(1H-imidazol-4(5)-yl)propyl ether derivatives.
    Kovalainen JT; Christiaans JA; Kotisaari S; Laitinen JT; Männistö PT; Tuomisto L; Gynther J
    J Med Chem; 1999 Apr; 42(7):1193-202. PubMed ID: 10197963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distribution and modulation of histamine H(3) receptors in basal ganglia and frontal cortex of healthy controls and patients with Parkinson's disease.
    Anichtchik OV; Peitsaro N; Rinne JO; Kalimo H; Panula P
    Neurobiol Dis; 2001 Aug; 8(4):707-16. PubMed ID: 11493035
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [125I]iodoproxyfan, a new antagonist to label and visualize cerebral histamine H3 receptors.
    Ligneau X; Garbarg M; Vizuete ML; Diaz J; Purand K; Stark H; Schunack W; Schwartz JC
    J Pharmacol Exp Ther; 1994 Oct; 271(1):452-9. PubMed ID: 7965746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The human histamine H3 receptor couples to GIRK channels in Xenopus oocytes.
    Sahlholm K; Nilsson J; Marcellino D; Fuxe K; Arhem P
    Eur J Pharmacol; 2007 Jul; 567(3):206-10. PubMed ID: 17537431
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stimulatory effect of (R) alpha-methylhistamine on duodenal HCO3- secretion in anaesthetized rats.
    Coruzzi G; Gambarelli E; Bertaccini G
    Ital J Gastroenterol; 1996 Dec; 28(9):520-2. PubMed ID: 9131398
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inverse agonist histamine H3 receptor PET tracers labelled with carbon-11 or fluorine-18.
    Hamill TG; Sato N; Jitsuoka M; Tokita S; Sanabria S; Eng W; Ryan C; Krause S; Takenaga N; Patel S; Zeng Z; Williams D; Sur C; Hargreaves R; Burns HD
    Synapse; 2009 Dec; 63(12):1122-32. PubMed ID: 19670309
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sensitivity of histamine H3 receptor agonist-stimulated [35S]GTP gamma[S] binding to pertussis toxin.
    Clark EA; Hill SJ
    Eur J Pharmacol; 1996 Jan; 296(2):223-5. PubMed ID: 8838460
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The histamine H3 receptor antagonist clobenpropit enhances GABA release to protect against NMDA-induced excitotoxicity through the cAMP/protein kinase A pathway in cultured cortical neurons.
    Dai H; Fu Q; Shen Y; Hu W; Zhang Z; Timmerman H; Leurs R; Chen Z
    Eur J Pharmacol; 2007 Jun; 563(1-3):117-23. PubMed ID: 17350613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ligands of the histamine H3-receptor: new potent antagonists of the 2-thioimidazole type.
    Plazzi PV; Mor M; Bordi F; Silva C; Rivara S; Caretta A; Ballabeni V; Impicciatore M; Vitali T
    Farmaco; 1997 May; 52(5):295-302. PubMed ID: 9274000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurochemical and behavioral effects of ciproxifan, a potent histamine H3-receptor antagonist.
    Ligneau X; Lin J; Vanni-Mercier G; Jouvet M; Muir JL; Ganellin CR; Stark H; Elz S; Schunack W; Schwartz J
    J Pharmacol Exp Ther; 1998 Nov; 287(2):658-66. PubMed ID: 9808693
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.